Anti-HER2 immunoliposomes for targeted drug delivery

Ann N Y Acad Sci. 1999;886:293-6. doi: 10.1111/j.1749-6632.1999.tb09440.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage*
  • Drug Carriers
  • Humans
  • Liposomes
  • Receptor, ErbB-2 / immunology*

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Liposomes
  • Receptor, ErbB-2